Form 4: Modular Medical Director Receives Stock Option Grant
Insider Transaction Report
Modular Medical, Inc. Director Ellen O'Connor Vos was granted 7,500 options to purchase common stock at an exercise price of $0.68, fully vested and exercisable on the grant date of June 30, 2025.
Summary
- Ellen O'Connor Vos, a Director of Modular Medical, Inc. (MODD), acquired 7,500 options to purchase common stock.
- The options have an exercise price of $0.68 per share.
- The grant date for these options was June 30, 2025.
- The options are fully vested and immediately exercisable as of the grant date.
- The options are set to expire on June 30, 2035.
- This grant was made in accordance with the Issuer's Outside Director Compensation Plan.
Sentiment
Score: 7
Explanation: The grant of stock options to a director is a positive sign of aligning management incentives with shareholder value, reflecting standard corporate compensation practices.
Positives
- The grant of stock options to a director aligns their interests with shareholders, incentivizing long-term company performance.
- The options were fully vested and exercisable on the grant date, providing immediate potential benefit to the director.
Future Outlook
N/A. This document is a Form 4, reporting an insider transaction, and does not provide forward-looking statements or guidance.
Industry Context
N/A. This Form 4 reports an individual insider transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | The grant of options was made in accordance with the Issuer's Outside Director Compensation Plan, indicating the ongoing use of established governance frameworks for director remuneration. | 06/30/2025 | Reinforces alignment of director incentives with long-term company performance and shareholder value. |
Related Party Transactions
- The grant of stock options to a director is a form of related party transaction, specifically compensation, conducted under the company's established Outside Director Compensation Plan.
Stakeholder Impact
- Shareholders: Potential positive impact through improved alignment of director incentives with company performance.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of earliest transaction; grant date for 7,500 stock options, fully vested and exercisable. |
| 07/02/2025 | Date the Form 4 was signed by the attorney-in-fact for Ellen O'Connor Vos. |
| 06/30/2035 | Expiration date of the granted stock options. |
Recommendation
holdKeywords
Modular Medical, MODD, Form 4, insider transaction, stock options, director compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.